Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group

per Bafaloukos, D, Papadimitriou, C, Linardou, H, Aravantinos, G, Papakostas, P, Skarlos, D, Kosmidis, P, Fountzilas, G, Gogas, H, Kalofonos, C, Dimopoulos, A M
Publicat 2004

Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study

per Koutras, A K, Kalogeras, K T, Dimopoulos, M-A, Wirtz, R M, Dafni, U, Briasoulis, E, Pectasides, D, Gogas, H, Christodoulou, C, Aravantinos, G, Zografos, G, Timotheadou, E, Papakostas, P, Linardou, H, Razis, E, Economopoulos, T, Kalofonos, H P, Fountzilas, G
Publicat 2008

Single-arm, open label prospective trial to assess prediction of the role of ERCC1/XPF complex in the response of advanced NSCLC patients to platinum-based chemotherapy

per Ganzinelli, M., Linardou, H., Alvisi, M.F., Caiola, E., Lo Russo, G., Cecere, F.L., Bettini, A.C., Psyrri, A., Milella, M., Rulli, E., Fabbri, A., De Maglie, M., Romanelli, P., Murray, S., Broggini, M., Marabese, M., Garassino, M.C.
Publicat a ESMO Open (2021)

1707P CureCancer digital tool in the routine clinical oncology practice facilitates PROs, communicating with HCPs, treatment adherence and “distancing interventions” during COVID-1...

per Galiti, D., Agelaki, S., Karampeazis, A., Linardou, H., Tsoukalas, N., Arvanitou, E., Georgopoulou, E., Vallilas, C., Syrigos, K., Sgourou, S., Kokkali-Zervos, S., Stamatogianni, E., Boutis, A., Christopoulou, A.N., Kontovinis, L., Mala, A., Rigas, G., Saridaki-Zoras, Z., Nicolatou-Galitis, O., Boukovinas, I.
Publicat a Ann Oncol (2020)

Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey

per Garrido, P., Adjei, A.A., Bajpai, J., Banerjee, S., Berghoff, A.S., Choo, S.P., Felip, E., Furness, A.J.S., Garralda, E., Haanen, J., Letsch, A., Linardou, H., Peters, S., Sessa, C., Tabernero, J., Tsang, J., Yang, J.C-.H., Garassino, M.C.
Publicat a ESMO Open (2021)

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

per Hellmann, M.D., Ciuleanu, T.-E., Pluzanski, A., Lee, J.S., Otterson, G.A., Audigier-Valette, C., Minenza, E., Linardou, H., Burgers, S., Salman, P., Borghaei, H., Ramalingam, S.S., Brahmer, J., Reck, M., O’Byrne, K.J., Geese, W.J., Green, G., Chang, H., Szustakowski, J., Bhagavatheeswaran, P., Healey, D., Fu, Y., Nathan, F., Paz-Ares, L.
Publicat a N Engl J Med (2018)